<?xml version="1.0" encoding="UTF-8"?>
<!-- generated by CLiX/Wiki2XML [MPI-Inf, MMCI@UdS] $LastChangedRevision: 92 $ on 16.04.2009 15:47:59[mciao0825] -->
<!DOCTYPE article SYSTEM "../article.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
<entity  confidence="0.9511911446218017" wordnetid="100001740">
<header>
<title>Progesterone</title>
<id>66432</id>
<revision>
<id>244681781</id>
<timestamp>2008-10-12T00:52:22Z</timestamp>
<contributor>
<username>Jfdwolff</username>
<id>46555</id>
</contributor>
</revision>
<categories>
<category>Progestagens</category>
<category>Neurosteroids</category>
</categories>
</header>
<bdy>

<table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" width="280" align="right" cellpadding="1" class="toccolours" border="0">

<row>
<col colspan="2" align="center">
 <image width="150px" src="Progesterone-2D-skeletal.png">
<caption>

 200px 
</caption>
</image>
</col>
</row>
<row>
<col colspan="2" align="center">
 <image width="150px" src="Progesterone-3D-vdW.png">
<caption>

 200px 
</caption>
</image>
</col>
</row>
<row>
<col colspan="2" align="center">
Progesterone</col>
</row>
<row>
<col colspan="2" align="center" bgcolor="#dddddd">
 <b>Systematic (<link xlink:type="simple" xlink:href="../503/3141503.xml">
IUPAC</link>) name</b></col>
</row>
<row>
<col colspan="2" style="text-align: center; vertical-align: top;" bgcolor="#eeeeee">
pregn-4-ene-3,20-dione</col>
</row>






<row>
<col colspan="2" bgcolor="#dddddd">
<b>Identifiers</b></col>
</row>
<row>
<col width="90" bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../815/160815.xml">
CAS number</link></col>
<col bgcolor="#eeeeee">
 <weblink xlink:type="simple" xlink:href="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?term=57-83-0&amp;rn=1">
57-83-0</weblink></col>
</row>
<row>
<col bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../770/2770.xml">
ATC code</link></col>
<col bgcolor="#eeeeee">
 <written_communication wordnetid="106349220" confidence="0.8">
<code wordnetid="106667317" confidence="0.8">
<link>
G03</link></code>
</written_communication>
<weblink xlink:type="simple" xlink:href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=G03DA04">
DA04</weblink></col>
</row>
<row>
<col bgcolor="#ddeeff">
 <institute wordnetid="108407330" confidence="0.8">
<association wordnetid="108049401" confidence="0.8">
<link xlink:type="simple" xlink:href="../723/2863723.xml">
PubChem</link></association>
</institute>
</col>
<col bgcolor="#eeeeee">
 <weblink xlink:type="simple" xlink:href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5994">
5994</weblink></col>
</row>
<row>
<col bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../731/3408731.xml">
DrugBank</link></col>
<col bgcolor="#eeeeee">
 <weblink xlink:type="simple" xlink:href="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD00700">
APRD00700</weblink></col>
</row>

<row>
<col colspan="2" bgcolor="#dddddd">
<b>Chemical data</b></col>
</row>
<row>
<col bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../043/7043.xml">
Formula</link></col>
<col bgcolor="#eeeeee">
 <link xlink:type="simple" xlink:href="../299/5299.xml">
C</link>21<link xlink:type="simple" xlink:href="../255/13255.xml">
H</link>30<link xlink:type="simple" xlink:href="../303/22303.xml">
O</link>2&nbsp;</col>
</row>
<row>
<col bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../836/19836.xml">
Mol. mass</link></col>
<col bgcolor="#eeeeee">
314.47</col>
</row>

<row>
<col bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../396/67396.xml">
Synonym</link>s</col>
<col bgcolor="#eeeeee">
4-pregnene-3,20-dione</col>
</row>
<row>
<col colspan="2" bgcolor="#dddddd">
<b>Physical data</b></col>
</row>

<row>
<col bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../283/40283.xml">
Melt. point</link></col>
<col bgcolor="#eeeeee">
126&nbsp;°C (259&nbsp;°F)</col>
</row>


<row>
<col bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../689/1821689.xml">
Spec. rot</link></col>
<col bgcolor="#eeeeee">
 [α]D</col>
</row>

<row>
<col colspan="2" bgcolor="#dddddd">
<b>Pharmacokinetic data</b></col>
</row>
<row>
<col style="vertical-align: top;" bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../021/769021.xml">
Bioavailability</link></col>
<col bgcolor="#eeeeee">
prolonged absorption, half-life approx 25-50 hours</col>
</row>
<row>
<col style="vertical-align: top;" bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../636/6025636.xml">
Protein binding</link></col>
<col bgcolor="#eeeeee">
96%-99%</col>
</row>
<row>
<col style="vertical-align: top;" bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../475/1173475.xml">
Metabolism</link></col>
<col bgcolor="#eeeeee">
 <link xlink:type="simple" xlink:href="../301/17384301.xml">
hepatic</link>to pregnanediols and pregnanolones</col>
</row>
<row>
<col style="vertical-align: top;" bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../099/3206099.xml">
Half life</link></col>
<col bgcolor="#eeeeee">
34.8-55.13 hours</col>
</row>
<row>
<col style="vertical-align: top;" bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../468/255468.xml">
Excretion</link></col>
<col bgcolor="#eeeeee">
renal</col>
</row>
<row>
<col colspan="2" bgcolor="#dddddd">
<b>Therapeutic considerations</b></col>
</row>

<row>
<col style="vertical-align: top;" bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../622/588622.xml">
Pregnancy cat.</link></col>
<col bgcolor="#eeeeee">
  
B (<body wordnetid="107965085" confidence="0.8">
<social_group wordnetid="107950920" confidence="0.8">
<political_orientation wordnetid="106212839" confidence="0.8">
<colony wordnetid="108374049" confidence="0.8">
<state wordnetid="108168978" confidence="0.8">
<political_unit wordnetid="108359949" confidence="0.8">
<group wordnetid="100031264" confidence="0.8">
<democracy wordnetid="106217103" confidence="0.8">
<link xlink:type="simple" xlink:href="../750/3434750.xml">
USA</link></democracy>
</group>
</political_unit>
</state>
</colony>
</political_orientation>
</social_group>
</body>
)</col>
</row>
<row>
<col style="vertical-align: top;" bgcolor="#ddeeff">
 <link xlink:type="simple" xlink:href="../840/1186840.xml">
Legal status</link></col>
<col bgcolor="#eeeeee"></col>
</row>

<row>
<col style="vertical-align: top;" bgcolor="#ddeeff">
 <work wordnetid="100575741" confidence="0.8">
<treatment wordnetid="100658082" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<care wordnetid="100654885" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<activity wordnetid="100407535" confidence="0.8">
<link xlink:type="simple" xlink:href="../816/334816.xml">
Routes</link></activity>
</psychological_feature>
</act>
</care>
</event>
</treatment>
</work>
</col>
<col bgcolor="#eeeeee">
 oral, <link xlink:type="simple" xlink:href="../996/1910996.xml">
implant</link></col>
</row>
</table>

<b>Progesterone</b> is a C-21 <link xlink:type="simple" xlink:href="../922/141922.xml">
steroid</link> <link xlink:type="simple" xlink:href="../311/13311.xml">
hormone</link> involved in the <link xlink:type="simple" xlink:href="../096/11096.xml">
female</link> <link xlink:type="simple" xlink:href="../003/88003.xml">
menstrual cycle</link>, <link xlink:type="simple" xlink:href="../587/1771587.xml">
pregnancy</link> (supports <it><link xlink:type="simple" xlink:href="../312/12312.xml">
gestation</link></it>) and <link xlink:type="simple" xlink:href="../542/1474542.xml">
embryogenesis</link> of humans and other species.  Progesterone belongs to a class of hormones called <link xlink:type="simple" xlink:href="../987/239987.xml">
progestogens</link>, and is the major naturally occurring human progestogen.  <p>

Progesterone should not be confused with <link xlink:type="simple" xlink:href="../990/239990.xml">
progestins</link>, which are synthetically produced <link xlink:type="simple" xlink:href="../987/239987.xml">
progestogens</link>.</p>

<sec>
<st>
Chemistry</st>
<p>

Progesterone was independently discovered by four research groups.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%221%22])">1</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%223%22])">3</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%224%22])">4</ref></p>
<p>

<physical_entity wordnetid="100001930" confidence="0.8">
<person wordnetid="100007846" confidence="0.8">
<medical_practitioner wordnetid="110305802" confidence="0.8">
<specialist wordnetid="110632576" confidence="0.8">
<gynecologist wordnetid="110154013" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<health_professional wordnetid="110165109" confidence="0.8">
<adult wordnetid="109605289" confidence="0.8">
<professional wordnetid="110480253" confidence="0.8">
<doctor wordnetid="110020890" confidence="0.8">
<link xlink:type="simple" xlink:href="../886/8335886.xml">
Willard Myron Allen</link></doctor>
</professional>
</adult>
</health_professional>
</causal_agent>
</gynecologist>
</specialist>
</medical_practitioner>
</person>
</physical_entity>
 co-discovered progesterone with his anatomy professor George Washington Corner at the University of Rochester Medical School in 1933. Allen first determined its melting point, molecular weight, and partial molecular structure. He also gave it the name <b>Progesterone</b> derived from <b>Proge</b>stational <b>Ster</b>oidal ket<b>one</b>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%225%22])">5</ref> </p>
<p>

Like other <link xlink:type="simple" xlink:href="../922/141922.xml">
steroid</link>s, progesterone consists of four interconnected <link xlink:type="simple" xlink:href="../257/13257.xml">
cyclic hydrocarbon</link>s. Progesterone contains <link xlink:type="simple" xlink:href="../803/16803.xml">
ketone</link> and oxygenated functional groups, as well as two <link xlink:type="simple" xlink:href="../839/19839.xml">
methyl</link> branches. Like all steroid hormones, it is <link xlink:type="simple" xlink:href="../136/14136.xml">
hydrophobic</link>.</p>

<ss1>
<st>
Synthesis</st>
<p>

Progesterone, * like all other <link xlink:type="simple" xlink:href="../922/141922.xml">
steroid</link> <link xlink:type="simple" xlink:href="../311/13311.xml">
hormone</link>s, is synthesized from <link xlink:type="simple" xlink:href="../714/2182714.xml">
pregnenolone</link>, a derivative of <link xlink:type="simple" xlink:href="../437/6437.xml">
cholesterol</link>. This conversion takes place in two steps. The 3-<link xlink:type="simple" xlink:href="../386/14386.xml">
hydroxyl</link> group is converted to a <link xlink:type="simple" xlink:href="../803/16803.xml">
keto</link> group and the <link xlink:type="simple" xlink:href="../246/6246.xml">
double bond</link> is moved to C-4, from C-5. </p>
<p>

<image location="center" width="350px" src="Reaction-Pregnenolone-Progesterone2.png" type="thumb">
<caption>

Conversion of Pregnenolone to Progesterone
</caption>
</image>
</p>
<p>

Progesterone is the precursor of the mineralocorticoid <link xlink:type="simple" xlink:href="../130/375130.xml">
aldosterone</link>, and after conversion to <link xlink:type="simple" xlink:href="../272/2418272.xml">
17-hydroxyprogesterone</link> (another natural progestogen) of <link xlink:type="simple" xlink:href="../380/335380.xml">
cortisol</link> and <link xlink:type="simple" xlink:href="../035/467035.xml">
androstenedione</link>. Androstenedione can be converted to <link xlink:type="simple" xlink:href="../983/30983.xml">
testosterone</link>, <link xlink:type="simple" xlink:href="../095/470095.xml">
estrone</link> and <link xlink:type="simple" xlink:href="../088/227088.xml">
estradiol</link>.</p>
<p>

<image location="center" width="350px" src="DHEA1.svg" type="thumb">
<caption>

Progesterone is important for <link xlink:type="simple" xlink:href="../130/375130.xml">
aldosterone</link> (<link xlink:type="simple" xlink:href="../700/530700.xml">
mineralocorticoid</link>) synthesis, as <link xlink:type="simple" xlink:href="../272/2418272.xml">
17-hydroxyprogesterone</link> is for <link xlink:type="simple" xlink:href="../380/335380.xml">
cortisol</link> (<link xlink:type="simple" xlink:href="../691/530691.xml">
glucocorticoid</link>), and <link xlink:type="simple" xlink:href="../035/467035.xml">
androstenedione</link> for <link xlink:type="simple" xlink:href="../491/689491.xml">
sex steroids</link>.
</caption>
</image>
</p>

</ss1>
</sec>
<sec>
<st>
Sources</st>
<p>

Progesterone is produced in the <link xlink:type="simple" xlink:href="../ury/23rd_century.xml">
adrenal gland</link>s, the gonads (specifically after ovulation in the <link xlink:type="simple" xlink:href="../976/528976.xml">
corpus luteum</link>), the brain, and, during pregnancy, in the <link xlink:type="simple" xlink:href="../166/67166.xml">
placenta</link>. </p>
<p>

In humans, increasing amounts of progesterone are produced during pregnancy:</p>
<p>

<list>
<entry level="1" type="bullet">

 Initially, the source is the corpus luteum that has been "rescued" by the presence of human chorionic gonadotropins (<link xlink:type="simple" xlink:href="../445/300445.xml">
hCG</link>) from the conceptus.</entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 However, after the 8th week production of progesterone shifts to the placenta. The placenta utilizes maternal cholesterol as the initial substrate, and most of the produced progesterone enters the maternal circulation, but some is picked up by the fetal circulation and used as substrate for fetal <link xlink:type="simple" xlink:href="../996/57996.xml">
corticosteroids</link>. At term the placenta produces about 250 mg progesterone per day.</entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 An additional source of progesterone is milk products. They contain much progesterone because on dairy farms cows are milked during pregnancy, when the progesterone content of the milk is high. After consumption of milk products the level of bioavailable progesterone goes up.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%226%22])">6</ref> This observation has resulted in concern that diets high in dairy products might induce pet and human diseases.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%227%22])">7</ref></entry>
</list>
</p>

</sec>
<sec>
<st>
Levels</st>
<p>

<image location="right" width="300 px" src="Estradiol.Cycle.JPG" type="thumb">
<caption>

Progesterone levels (black line) during the menstrual cycle
</caption>
</image>

In women, progesterone levels are relatively low during the preovulatory phase of the <link xlink:type="simple" xlink:href="../003/88003.xml">
menstrual cycle</link>, rise after <link xlink:type="simple" xlink:href="../856/161856.xml">
ovulation</link>, and are elevated during the luteal phase. Progesterone levels tend to be  2 ng/ml prior to ovulation, and &amp;gt; 5 ng/ml after ovulation. If <link xlink:type="simple" xlink:href="../587/1771587.xml">
pregnancy</link> occurs, progesterone levels are initially maintained at luteal levels. With the onset of the luteal-placental shift in progesterone support of the pregnancy, levels start to rise further and may reach 100-200 ng/ml at term. Whether a decrease in progesterone levels is critical for the initiation of <link xlink:type="simple" xlink:href="../449/83449.xml">
labor</link> has been argued and may be species-specific. After delivery of the placenta and during lactation, progesterone levels are very low. </p>
<p>

Progesterone levels are relatively low in children and postmenopausal women.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%228%22])">8</ref> Adult males have levels similar to those in women during the follicular phase of the menstrual cycle.</p>

</sec>
<sec>
<st>
Effects</st>
<p>

Progesterone exerts its action primarily through the intracellular <link xlink:type="simple" xlink:href="../534/2246534.xml">
progesterone receptor</link> although a distinct, membrane bound progesterone receptor has also been postulated.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%229%22])">9</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2210%22])">10</ref> Progesterone has a number of physiological effects which are amplified in the presence of <link xlink:type="simple" xlink:href="../581/22581.xml">
estrogen</link>.  Estrogen through estrogen receptors <link xlink:type="simple" xlink:href="../121/553121.xml">
upregulates</link> the <link xlink:type="simple" xlink:href="../266/159266.xml">
expression</link> of progesterone receptors. <ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2211%22])">11</ref></p>

<ss1>
<st>
Reproductive system</st>
<p>

Progesterone is sometimes called the "hormone of pregnancy",<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2212%22])">12</ref> and it has many roles relating to the development of the fetus: </p>
<p>

<list>
<entry level="1" type="bullet">

 Progesterone converts the <link xlink:type="simple" xlink:href="../509/9509.xml">
endometrium</link> to its secretory stage to prepare the uterus for implantation. At the same time progesterone affects the vaginal <link xlink:type="simple" xlink:href="../641/299641.xml">
epithelium</link> and <link xlink:type="simple" xlink:href="../738/5738.xml#xpointer(//*[./st=%22Cervical_mucus%22])">
cervical mucus</link>, making the <link xlink:type="simple" xlink:href="../188/501188.xml">
mucus</link> thick and impermeable to <link xlink:type="simple" xlink:href="../040/2324040.xml">
sperm</link>. If pregnancy does not occur, progesterone levels will decrease, leading, in the human, to <link xlink:type="simple" xlink:href="../203/38203.xml">
menstruation</link>. Normal menstrual bleeding is progesterone withdrawal bleeding.</entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 During implantation and <link xlink:type="simple" xlink:href="../312/12312.xml">
gestation</link>, progesterone appears to decrease the maternal <link xlink:type="simple" xlink:href="../958/14958.xml">
immune</link> response to allow for the acceptance of the pregnancy. </entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 Progesterone decreases contractility of the uterine <link xlink:type="simple" xlink:href="../381/300381.xml">
smooth muscle</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2212%22])">12</ref></entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 In addition progesterone inhibits <link xlink:type="simple" xlink:href="../279/250279.xml">
lactation</link> during pregnancy. The fall in progesterone levels following delivery is one of the triggers for milk production.</entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 A drop in progesterone levels is possibly one step that facilitates the onset of <link xlink:type="simple" xlink:href="../449/83449.xml">
labor</link>. </entry>
</list>
</p>
<p>

The <link xlink:type="simple" xlink:href="../873/10873.xml">
fetus</link> <link xlink:type="simple" xlink:href="../374/20374.xml">
metabolize</link>s placental progesterone in the production of <link xlink:type="simple" xlink:href="../ury/23rd_century.xml">
adrenal</link> mineralo- and glucosteroids.</p>

</ss1>
<ss1>
<st>
Nervous system</st>
<p>

Progesterone, like <link xlink:type="simple" xlink:href="../714/2182714.xml">
pregnenolone</link> and <link xlink:type="simple" xlink:href="../807/8807.xml">
dehydroepiandrosterone</link>, belongs to the group of <link xlink:type="simple" xlink:href="../301/2404301.xml">
neurosteroid</link>s that are found in high concentrations in certain areas in the brain and are synthesized there. </p>
<p>

<link xlink:type="simple" xlink:href="../301/2404301.xml">
Neurosteroids</link> affect <link xlink:type="simple" xlink:href="../809/27809.xml">
synaptic functioning</link>, are neuroprotective, and affect <link xlink:type="simple" xlink:href="../319/19319.xml">
myelin</link>ation.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2213%22])">13</ref> They are investigated for their potential to improve <link xlink:type="simple" xlink:href="../844/18844.xml">
memory</link> and <link xlink:type="simple" xlink:href="../238/106238.xml">
cognitive ability</link>. </p>
<p>

Progesterone as neuroprotectant affects regulation of <link xlink:type="simple" xlink:href="../ury/25th_century.xml">
apoptotic</link> genes.  </p>
<p>

Its effect as a neurosteroid works predominantly through the <link xlink:type="simple" xlink:href="../574/1113574.xml">
GSK-3</link> beta pathway, as an inhibitor.  (Other GSK-3 beta inhibitors include <link xlink:type="simple" xlink:href="../531/4531.xml">
bipolar</link> mood stabilizers, <link xlink:type="simple" xlink:href="../561/17561.xml">
lithium</link> and <link xlink:type="simple" xlink:href="../761/57761.xml">
valproic acid</link>.)</p>

</ss1>
<ss1>
<st>
Other systems</st>

<p>

<list>
<entry level="1" type="bullet">

 It raises <link xlink:type="simple" xlink:href="../297/1228297.xml">
epidermal growth factor-1</link> levels, a factor often used to induce proliferation, and used to sustain cultures, of <link xlink:type="simple" xlink:href="../783/27783.xml">
stem cell</link>s.</entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 It increases core temperature (thermogenic function) during ovulation.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2214%22])">14</ref></entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 It reduces <link xlink:type="simple" xlink:href="../177/173177.xml">
spasm</link> and relaxes <link xlink:type="simple" xlink:href="../381/300381.xml">
smooth muscle</link>. <link xlink:type="simple" xlink:href="../449/308449.xml">
Bronchi</link> are widened and <link xlink:type="simple" xlink:href="../188/501188.xml">
mucus</link> regulated. (<structure wordnetid="105225602" confidence="0.8">
<cause wordnetid="107326557" confidence="0.8">
<beginning wordnetid="107290905" confidence="0.8">
<receptor wordnetid="105608868" confidence="0.8">
<happening wordnetid="107283608" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<origin wordnetid="107323922" confidence="0.8">
<factor wordnetid="107327805" confidence="0.8">
<part wordnetid="109385911" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<body_part wordnetid="105220461" confidence="0.8">
<link xlink:type="simple" xlink:href="../534/2246534.xml">
Progesterone receptor</link></body_part>
</psychological_feature>
</part>
</factor>
</origin>
</event>
</happening>
</receptor>
</beginning>
</cause>
</structure>
s are widely present in <link xlink:type="simple" xlink:href="../447/69447.xml">
submucosal tissue</link>.)</entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 It acts as an <link xlink:type="simple" xlink:href="../425/70425.xml">
antiinflammatory</link> agent and regulates the <link xlink:type="simple" xlink:href="../958/14958.xml">
immune response</link>. </entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 It reduces <link xlink:type="simple" xlink:href="../020/197020.xml">
gall-bladder</link> activity.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2215%22])">15</ref></entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 It normalizes <link xlink:type="simple" xlink:href="../997/3997.xml">
blood</link> clotting and vascular tone, <link xlink:type="simple" xlink:href="../420/34420.xml">
zinc</link> and <link xlink:type="simple" xlink:href="../293/125293.xml">
copper</link> levels, <link xlink:type="simple" xlink:href="../230/4230.xml">
cell</link> <link xlink:type="simple" xlink:href="../303/22303.xml">
oxygen</link> levels, and use of fat stores for energy.  </entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 It assists in <link xlink:type="simple" xlink:href="../078/30078.xml">
thyroid</link> function, in <link xlink:type="simple" xlink:href="../099/4099.xml">
bone</link> building by <link xlink:type="simple" xlink:href="../986/419986.xml">
osteoblast</link>s, in <link xlink:type="simple" xlink:href="../099/4099.xml">
bone</link>, <link xlink:type="simple" xlink:href="../756/68756.xml">
teeth</link>, <link xlink:type="simple" xlink:href="../738/908738.xml">
gum</link>s, <link xlink:type="simple" xlink:href="../242/210242.xml">
joint</link>, <link xlink:type="simple" xlink:href="../865/144865.xml">
tendon</link>, <link xlink:type="simple" xlink:href="../874/17874.xml">
ligament</link> and <link xlink:type="simple" xlink:href="../978/27978.xml">
skin</link> <link xlink:type="simple" xlink:href="../779/1264779.xml">
resilience</link> and in some cases healing by regulating various types of <link xlink:type="simple" xlink:href="../058/6058.xml">
collagen</link>, and in nerve function and healing by regulating <link xlink:type="simple" xlink:href="../319/19319.xml">
myelin</link>. </entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 It appears to prevent <link xlink:type="simple" xlink:href="../809/412809.xml">
endometrial cancer</link> (involving the uterine lining) by regulating the effects of estrogen.</entry>
</list>
</p>

</ss1>
</sec>
<sec>
<st>
Medical applications</st>

<p>

The use of progesterone and its analogues have many medical applications -- both to address acute situations, and to address the long-term decline of natural progesterone levels. Because of the poor bioavailability of progesterone when taken orally, many synthetic progestins have been designed. However, the roles of progesterone may not be fulfilled by the synthetic progestins which in some cases were designed solely to <link xlink:type="simple" xlink:href="../151/247151.xml">
mimic</link> progesterone's <link xlink:type="simple" xlink:href="../863/31863.xml">
uterine</link> effects.  </p>

<ss1>
<st>
Bioavailability</st>
<p>

Progesterone is poorly absorbed by oral ingestion unless <link xlink:type="simple" xlink:href="../271/1213271.xml">
micronised</link> and in oil, or with fatty foods; it does not dissolve in water. Products such as Prometrium, Utrogestan, Minagest and Microgest are therefore capsules containing micronised progesterone in oil - in all three mentioned the oil is <link xlink:type="simple" xlink:href="../602/55602.xml">
peanut</link> oil, which may cause serious <link xlink:type="simple" xlink:href="../313/55313.xml">
allergic reactions</link> in some people, but compounding <link xlink:type="simple" xlink:href="../350/297350.xml">
pharmacies</link>, which have the facilities and licenses to make their own products, can use alternatives. Vaginal and rectal application is also effective, with products such as CRINONE and PROCHIEVE bioadhesive progesterone vaginal gels (the only progesterone products FDA-approved for use in infertility and during pregnancy) and Cyclogest, which is progesterone in <link xlink:type="simple" xlink:href="../218/894218.xml">
cocoa butter</link> in the form of <link xlink:type="simple" xlink:href="../491/574491.xml">
pessaries</link>. Progesterone can be given by <form wordnetid="106290637" confidence="0.8">
<word wordnetid="106286395" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<language_unit wordnetid="106284225" confidence="0.8">
<link xlink:type="simple" xlink:href="../909/665909.xml">
injection</link></language_unit>
</part>
</word>
</form>
, but because it has a short <link xlink:type="simple" xlink:href="../320/330320.xml">
half-life</link> they need to be daily. Implants, for a longer period, are also available. Marketing of progesterone phamaceutical products, country to country, varies considerably, with many countries having no oral progesterone products marketed, but they can usually be specially imported by pharmacies through international <link xlink:type="simple" xlink:href="../103/63103.xml">
wholesaler</link>s.</p>
<p>

"Natural progesterone" products derived from <link xlink:type="simple" xlink:href="../275/3152275.xml">
yams</link>, do not require a prescription. Wild yams contain a <link>
plant steroid</link> called <link xlink:type="simple" xlink:href="../590/6887590.xml">
diosgenin</link>, however there is no evidence that the human body can <link xlink:type="simple" xlink:href="../374/20374.xml">
metabolize</link> diosgenin into progesterone.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2216%22])">16</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2217%22])">17</ref> Diosgenin can however be chemically converted into progesterone in the lab.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2218%22])">18</ref></p>

</ss1>
<ss1>
<st>
Specific uses</st>
<p>

<list>
<entry level="1" type="bullet">

Progesterone is used to support pregnancy in Assisted Reproductive Technology (ART) cycles such as In-vitro Fertilization (IVF). While daily intramuscular injections of progesterone have been the standard route of administration, a recent meta-analysis showed that the intravaginal route with an appropriate dose and dosing frequency is equivalent to daily intramuscular injections.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2219%22])">19</ref></entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

Progesterone is used to control <link>
anovulatory bleeding</link>. It is also used to prepare uterine lining in <link xlink:type="simple" xlink:href="../242/179242.xml">
infertility</link> therapy and to support early pregnancy. Patients with <link xlink:type="simple" xlink:href="../093/1166093.xml">
recurrent pregnancy loss</link> due to inadequate progesterone production may receive progesterone.</entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 Progesterone is being investigated as potentially beneficial in treating <link xlink:type="simple" xlink:href="../603/50603.xml">
multiple sclerosis</link>, since the characteristic deterioration of nerve <link xlink:type="simple" xlink:href="../319/19319.xml">
myelin</link> insulation halts during pregnancy, when progesterone levels are raised; deterioration commences again when the levels drop.</entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

Vaginally dosed progesterone is being investigated as potentially beneficial in preventing preterm birth in women at risk for preterm birth. The initial study by Fonseca suggested that vaginal progesterone could prevent preterm birth in women with a history of preterm birth.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2220%22])">20</ref></entry>
</list>
</p>
<p>

A subsequent and larger study showed that vaginal progesterone was no better than placebo in preventing recurrent preterm birth in women with a history of a previous preterm birth,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2221%22])">21</ref> but a planned secondary analysis of the data in this trial showed that women with a short cervix at baseline in the trial had benefit in two ways: a reduction in births less than 32 weeks and a reduction in both the frequency and the time their babies were in intensive care.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2222%22])">22</ref> In another trial, vaginal progesterone was shown to be better than placebo in reducing preterm birth prior to 34 weeks in women with an extremely short cervix at baseline.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2223%22])">23</ref> An editorial by Roberto Romero discusses the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2224%22])">24</ref></p>
<p>

<list>
<entry level="1" type="bullet">

 Progesterone is used in <link xlink:type="simple" xlink:href="../089/14673089.xml">
hormone replacement therapy</link> for <link xlink:type="simple" xlink:href="../839/611839.xml">
transwomen</link>, and some women with <link xlink:type="simple" xlink:href="../185/15185.xml">
intersex</link> conditions - especially when synthetic progestins have been ineffective or caused side-effects - since normal <link xlink:type="simple" xlink:href="../489/4489.xml">
breast</link> tissue cannot develop except in the presence of both progestogen and <link xlink:type="simple" xlink:href="../581/22581.xml">
estrogen</link>. <link xlink:type="simple" xlink:href="../440/311440.xml">
Mammary gland</link>ular tissue is otherwise <link xlink:type="simple" xlink:href="../471/906471.xml">
fibrotic</link>, the breast shape <link xlink:type="simple" xlink:href="../427/782427.xml">
conical</link> and the <link xlink:type="simple" xlink:href="../247/250247.xml">
areola</link> immature. Progesterone can correct those even after years of inadequate hormonal treatment. Research usually cited against such value was conducted using Provera, a synthetic progestin. Progesterone also has a role in skin elasticity and bone strength, in <link xlink:type="simple" xlink:href="../962/491962.xml">
respiration</link>, in nerve tissue and in <link xlink:type="simple" xlink:href="../054/3647054.xml">
female sexuality</link>, and the presence of progesterone receptors in certain muscle and fat tissue may hint at a role in <link xlink:type="simple" xlink:href="../179/197179.xml">
sexually-dimorphic</link> proportions of those.</entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 Progesterone <link xlink:type="simple" xlink:href="../168/654168.xml">
receptor antagonist</link>s, or <link xlink:type="simple" xlink:href="../470/2537470.xml">
selective progesterone receptor modulator</link>s (SPRM)s, such as <link xlink:type="simple" xlink:href="../415/181415.xml">
RU-486</link> (<link xlink:type="simple" xlink:href="../415/181415.xml">
Mifepristone</link>), can be used to prevent conception or induce <link xlink:type="simple" xlink:href="../287/1188287.xml">
medical abortion</link>s.</entry>
</list>
</p>
<p>

Note that methods of <link xlink:type="simple" xlink:href="../285/4482285.xml">
hormonal contraception</link> do not contain progesterone but a <link xlink:type="simple" xlink:href="../990/239990.xml">
progestin</link>.</p>
<p>

Progesterone may affect male behavior.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2225%22])">25</ref></p>
<p>

Lawn chemicals and no-till agricultual practices may disturb both estrogen and progesterone metabolism. </p>

</ss1>
<ss1>
<st>
Aging</st>

<p>

Since most progesterone in males is created during testicular production of <link xlink:type="simple" xlink:href="../983/30983.xml">
testosterone</link>, and most in females by the <link xlink:type="simple" xlink:href="../710/22710.xml">
ovaries</link>, the shutting down (whether by natural or chemical means), or removal, of those inevitably causes a considerable reduction in progesterone levels. Previous concentration upon the role of <link xlink:type="simple" xlink:href="../987/239987.xml">
progestagen</link>s (progesterone and molecules with similar effects) in female reproduction, when progesterone was simply considered a "female hormone", obscured the significance of progesterone elsewhere in both sexes.</p>
<p>

The tendency for progesterone to have a regulatory effect, the presence of progesterone <link xlink:type="simple" xlink:href="../480/569480.xml">
receptor</link>s in many types of body tissue, and the pattern of deterioration (or <link xlink:type="simple" xlink:href="../214/31214.xml">
tumor</link> formation) in many of those increasing in later years when progesterone levels have dropped, is prompting widespread research into the potential value of maintaining progesterone levels in both males and females.</p>

</ss1>
<ss1>
<st>
Brain damage</st>

<p>

It has been observed in animal models that females have reduced susceptibility to <link xlink:type="simple" xlink:href="../414/1057414.xml">
traumatic brain injury</link> and this protective effect has been hypothesized to be caused by increased circulating levels of <link xlink:type="simple" xlink:href="../581/22581.xml">
estrogen</link> and progesterone in females.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2226%22])">26</ref>  A number of additional animal studies have confirmed that progesterone has neuroprotective effects when administered shortly after traumatic brain injury.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2227%22])">27</ref>  Encouraging results have also been reported in human clinical trials.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2228%22])">28</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2229%22])">29</ref></p>
<p>

The mechanism of progesterone protective effects may be the reduction of inflammation which follows brain trauma.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2230%22])">30</ref></p>

</ss1>
</sec>
<sec>
<st>
See also</st>
<p>

<list>
<entry level="1" type="bullet">

<physical_entity wordnetid="100001930" confidence="0.8">
<person wordnetid="100007846" confidence="0.8">
<medical_practitioner wordnetid="110305802" confidence="0.8">
<specialist wordnetid="110632576" confidence="0.8">
<gynecologist wordnetid="110154013" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<health_professional wordnetid="110165109" confidence="0.8">
<adult wordnetid="109605289" confidence="0.8">
<professional wordnetid="110480253" confidence="0.8">
<doctor wordnetid="110020890" confidence="0.8">
<link xlink:type="simple" xlink:href="../886/8335886.xml">
Willard Myron Allen</link></doctor>
</professional>
</adult>
</health_professional>
</causal_agent>
</gynecologist>
</specialist>
</medical_practitioner>
</person>
</physical_entity>
</entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../134/1243134.xml">
Bioidentical hormone replacement therapy</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../263/1213263.xml">
Prometrium</link></entry>
</list>
</p>

</sec>
<sec>
<st>
References</st>

<p>

<reflist>
<entry id="1">
 <cite style="font-style:normal">Allen WM&#32;(1935).&#32;"The isolation of crystalline progestin". <it>Science</it>&#32;<b>82</b>&#32;(2118): 89–93. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1126%2Fscience.82.2118.89">
10.1126/science.82.2118.89</weblink>. PMID 17747122.</cite>&nbsp;</entry>
<entry id="2">
 <cite style="font-style:normal">Butenandt A, Westphal U&#32;(1934).&#32;"Zur Isolierung und Charakterisierung des Corpusluteum-Hormons". <it>Berichte Deutsche chemische Gesellschaft</it>&#32;<b>67</b>: 1440–1442.</cite>&nbsp;</entry>
<entry id="3">
 <cite style="font-style:normal">Hartmann M, Wettstein A&#32;(1934).&#32;"Ein krystallisiertes Hormon aus Corpus luteum". <it>Helvetica Chimica Acta</it>&#32;<b>17</b>: 878–882. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fhlca.193401701111">
10.1002/hlca.193401701111</weblink>.</cite>&nbsp;</entry>
<entry id="4">
 <cite style="font-style:normal">Slotta KH, Ruschig H, Fels E&#32;(1934).&#32;"Reindarstellung der Hormone aus dem Corpusluteum". <it>Berichte Deutsche chemische Gesellschaft</it>&#32;<b>67</b>: 1270–1273.</cite>&nbsp;</entry>
<entry id="5">
 <cite style="font-style:normal">Allen WM&#32;(1970).&#32;"Progesterone: how did the name originate?". <it>South. Med. J.</it>&#32;<b>63</b>&#32;(10): 1151–5. PMID 4922128.</cite>&nbsp;</entry>
<entry id="6">
Goodson III WH, Handagama P, Moore II DH, Dairkee S&#32;(2007-12-13).&#32;"<weblink xlink:type="simple" xlink:href="http://www.abstracts2view.com/sabcs/view.php?nu=SABCS07L_1108&amp;terms">
Milk products are a source of dietary progesterone</weblink>"&#32;abstract # 2028.&#32;  30th Annual San Antonio Breast Cancer Symposium.&#32;Retrieved on <link>
2008-03-12</link>.</entry>
<entry id="7">
Elisabeth Rieping&#32;(2008-01-01).&#32;"<weblink xlink:type="simple" xlink:href="http://www.erieping.de/english.htm">
Breast Cancer and Progesterone from the Milk of Pregnant Cows</weblink>".&#32;Retrieved on <link>
2008-03-12</link>.</entry>
<entry id="8">
NIH Clinical Center&#32;(2004-08-16).&#32;"<weblink xlink:type="simple" xlink:href="http://cclnprod.cc.nih.gov/dlm/testguide.nsf/Index/CB26894E1EB28DEF85256BA5005B000E?OpenDocument">
Progesterone Historical Reference Ranges</weblink>".&#32;  United States National Institutes of Health.&#32;Retrieved on <link>
2008-03-12</link>.</entry>
<entry id="9">
 <cite style="font-style:normal">Luconi M, Bonaccorsi L, Maggi M, Pecchioli P, Krausz C, Forti G, Baldi E&#32;(1998).&#32;"Identification and characterization of functional nongenomic progesterone receptors on human sperm membrane". <it>J. Clin. Endocrinol. Metab.</it>&#32;<b>83</b>&#32;(3): 877–85. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1210%2Fjc.83.3.877">
10.1210/jc.83.3.877</weblink>. PMID 9506743.</cite>&nbsp;</entry>
<entry id="10">
 <cite style="font-style:normal">Jang S, Yi LS&#32;(2005).&#32;"Identification of a 71 kDa protein as a putative non-genomic membrane progesterone receptor in boar spermatozoa". <it>J. Endocrinol.</it>&#32;<b>184</b>&#32;(2): 417–25. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1677%2Fjoe.1.05607">
10.1677/joe.1.05607</weblink>. PMID 15684349.</cite>&nbsp;</entry>
<entry id="11">
 <cite style="font-style:normal">Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P&#32;(1990).&#32;"Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B". <it>EMBO J.</it>&#32;<b>9</b>&#32;(5): 1603–14. PMID 2328727.</cite>&nbsp;</entry>
<entry id="12">
Bowen R&#32;(2000-08-06).&#32;"<weblink xlink:type="simple" xlink:href="http://www.vivo.colostate.edu/hbooks/pathphys/reprod/placenta/endocrine.html">
Placental Hormones</weblink>".&#32;Retrieved on <link>
2008-03-12</link>.</entry>
<entry id="13">
 <cite style="font-style:normal">Schumacher M, Guennoun R, Robert F, et al&#32;(2004).&#32;"Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination". <it>Growth Horm. IGF Res.</it>&#32;<b>14 Suppl A</b>: S18–33. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.ghir.2004.03.007">
10.1016/j.ghir.2004.03.007</weblink>. PMID 15135772.</cite>&nbsp;</entry>
<entry id="14">
<university wordnetid="108286163" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../451/2177451.xml">
Physiology at MCG</link></university>
 <it><weblink xlink:type="simple" xlink:href="http://www.lib.mcg.edu/edu/eshuphysio/program/section5/5ch9/s5ch9_13.htm">
5/5ch9/s5ch9_13</weblink>''</it></entry>
<entry id="15">
 <cite style="font-style:normal">Hould FS, Fried GM, Fazekas AG, Tremblay S, Mersereau WA&#32;(1988).&#32;"Progesterone receptors regulate gallbladder motility". <it>J. Surg. Res.</it>&#32;<b>45</b>&#32;(6): 505–12. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2F0022-4804%2888%2990137-0">
10.1016/0022-4804(88)90137-0</weblink>. PMID 3184927.</cite>&nbsp;</entry>
<entry id="17">
 <cite style="font-style:normal">Komesaroff PA, Black CV, Cable V, Sudhir K&#32;(2001).&#32;"Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women". <it>Climacteric</it>&#32;<b>4</b>&#32;(2): 144–50. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1080%2F713605087">
10.1080/713605087</weblink>. PMID 11428178.</cite>&nbsp;</entry>
<entry id="16">
 <cite style="font-style:normal">Zava DT, Dollbaum CM, Blen M&#32;(1998).&#32;"<weblink xlink:type="simple" xlink:href="http://www.cancersupportivecare.com/estrogenherbref.html#31">
Estrogen and progestin bioactivity of foods, herbs, and spices</weblink>". <it>Proc. Soc. Exp. Biol. Med.</it>&#32;<b>217</b>&#32;(3): 369–78. PMID 9492350.</cite>&nbsp;</entry>
<entry id="19">
 <cite style="font-style:normal">Zarutskiea PW, Phillips JA&#32;(2007).&#32;"Re-analysis of vaginal progesterone as luteal phase support (LPS) in assisted reproduction (ART) cycles". <it>Fertility and Sterility</it>&#32;<b>88</b>&#32;(supplement 1): S113. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.fertnstert.2007.07.365">
10.1016/j.fertnstert.2007.07.365</weblink>.</cite>&nbsp;</entry>
<entry id="18">
 <cite style="font-style:normal">Marker RE, Krueger J&#32;(1940).&#32;"Sterols. CXII. Sapogenins. XLI. The Preparation of Trillin and its Conversion to Progesterone". <it>J. Am. Chem. Soc.</it>&#32;<b>62</b>&#32;(12): 3349–3350. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1021%2Fja01869a023">
10.1021/ja01869a023</weblink>.</cite>&nbsp;</entry>
<entry id="21">
 <cite style="font-style:normal">O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, Soma-Pillay P, Porter K, How H, Schackis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW&#32;(2007).&#32;"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial". <it>Ultrasound Obstet Gynecol</it>&#32;<b>30</b>&#32;(5): 687–96. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fuog.5158">
10.1002/uog.5158</weblink>. PMID 17899572.</cite>&nbsp;</entry>
<entry id="20">
 <cite style="font-style:normal">da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M&#32;(2003).&#32;"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study". <it>Am. J. Obstet. Gynecol.</it>&#32;<b>188</b>&#32;(2): 419–24. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1067%2Fmob.2003.41">
10.1067/mob.2003.41</weblink>. PMID 12592250.</cite>&nbsp;</entry>
<entry id="23">
 <cite style="font-style:normal">Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH&#32;(2007).&#32;"Progesterone and the risk of preterm birth among women with a short cervix". <it>N. Engl. J. Med.</it>&#32;<b>357</b>&#32;(5): 462–9. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1056%2FNEJMoa067815">
10.1056/NEJMoa067815</weblink>. PMID 17671254.</cite>&nbsp;</entry>
<entry id="22">
 <cite style="font-style:normal">DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW&#32;(2007).&#32;"Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial". <it>Ultrasound Obstet Gynecol</it>&#32;<b>30</b>&#32;(5): 697–705. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fuog.5159">
10.1002/uog.5159</weblink>. PMID 17899571.</cite>&nbsp;</entry>
<entry id="25">
 <cite style="font-style:normal">Schneider JS, Stone MK, Wynne-Edwards KE, Horton TH, Lydon J, O'Malley B, Levine JE&#32;(2003).&#32;"Progesterone receptors mediate male aggression toward infants". <it>Proc. Natl. Acad. Sci. U.S.A.</it>&#32;<b>100</b>&#32;(5): 2951–6. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1073%2Fpnas.0130100100">
10.1073/pnas.0130100100</weblink>. PMID 12601162.</cite>&nbsp;</entry>
<entry id="24">
 <cite style="font-style:normal">Romero R&#32;(2007).&#32;"Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment". <it>Ultrasound Obstet Gynecol</it>&#32;<b>30</b>&#32;(5): 675–86. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fuog.5174">
10.1002/uog.5174</weblink>. PMID 17899585.</cite>&nbsp;</entry>
<entry id="27">
 <cite style="font-style:normal">Gibson CL, Gray LJ, Bath PM, Murphy SP&#32;(February 2008).&#32;"Progesterone for the treatment of experimental brain injury; a systematic review". <it>Brain</it>&#32;<b>131</b>&#32;(Pt 2): 318–28. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1093%2Fbrain%2Fawm183">
10.1093/brain/awm183</weblink>. PMID 17715141.</cite>&nbsp;</entry>
<entry id="26">
 <cite style="font-style:normal">Roof RL, Hall ED&#32;(May 2000).&#32;"Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone". <it>J. Neurotrauma</it>&#32;<b>17</b>&#32;(5): 367–88. PMID 10833057.</cite>&nbsp;</entry>
<entry id="29">
 <cite style="font-style:normal">Xiao G, Wei J, Yan W, Wang W, Lu Z&#32;(April 2008).&#32;"Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial". <it>Crit Care</it>&#32;<b>12</b>&#32;(2): R61. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1186%2Fcc6887">
10.1186/cc6887</weblink>. PMID 18447940.</cite>&nbsp;</entry>
<entry id="28">
 <cite style="font-style:normal">Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, Salomone JP, Dent LL, Harris OA, Ander DS, Lowery DW, Patel MM, Denson DD, Gordon AB, Wald MM, Gupta S, Hoffman SW, Stein DG&#32;(April 2007).&#32;"ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury". <it>Ann Emerg Med</it>&#32;<b>49</b>&#32;(4): 391–402, 402.e1–2. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.annemergmed.2006.07.932">
10.1016/j.annemergmed.2006.07.932</weblink>. PMID 17011666.</cite>&nbsp;</entry>
<entry id="30">
 <cite style="font-style:normal">Pan DS, Liu WG, Yang XF, Cao F&#32;(October 2007).&#32;"Inhibitory effect of progesterone on inflammatory factors after experimental traumatic brain injury". <it>Biomed. Environ. Sci.</it>&#32;<b>20</b>&#32;(5): 432–8. PMID 18188998.</cite>&nbsp;</entry>
</reflist>
</p>

</sec>
<sec>
<st>
Additional images</st>



</sec>
<sec>
<st>
External links</st>
<p>

<list>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../794/1076794.xml">
MeSH</link> <it><weblink xlink:type="simple" xlink:href="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&amp;term=Progesterone">
Progesterone</weblink>''</it></entry>
<entry level="1" type="bullet">

 Kimball JW&#32;(2007-05-27).&#32;"<weblink xlink:type="simple" xlink:href="http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/P/Progesterone.html">
Progesterone</weblink>".&#32;<it>Kimball's Biology Pages</it>.&#32;Retrieved on <link>
2008-06-18</link>.</entry>
<entry level="1" type="bullet">

 "<weblink xlink:type="simple" xlink:href="http://www.pms-menopause-progesterone.org/progesterone/">
Progesterone Resource Center</weblink>".&#32;<it>PMS, Menopause, and Progesterone Resource Center</it>.&#32;  Oasis Advanced Wellness, Inc.&#32;Retrieved on <link>
2008-06-18</link>.</entry>
</list>
</p>

<p>

<table style=";" class="navbox" cellspacing="0">
<row>
<col style="padding:2px;">
<table style="width:100%;background:transparent;color:inherit;;" class="nowraplinks collapsible autocollapse " cellspacing="0">
<row>
<header colspan="2" style=";background:#efefef" class="navbox-title">
<link xlink:type="simple" xlink:href="../312/9312.xml">
Endocrine system</link>: <link xlink:type="simple" xlink:href="../311/13311.xml">
hormone</link>s/<link xlink:type="simple" xlink:href="../446/1223446.xml">
endocrine glands</link> (<it><link xlink:type="simple" xlink:href="../372/248372.xml">
Peptide hormone</link>s</it>, <it><link xlink:type="simple" xlink:href="../579/328579.xml">
Steroid hormone</link>s</it>)</header>
</row>
<row style="height:2px;">

</row>
<row>
<col style=";background:#efefef;;" class="navbox-group">
Hypothalamic-pituitary</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<b> <link xlink:type="simple" xlink:href="../685/58685.xml">
Hypothalamus</link>:</b> <link xlink:type="simple" xlink:href="../993/183993.xml">
TRH</link>, <substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../943/183943.xml">
CRH</link></hormone>
</part>
</liquid_body_substance>
</body_substance>
</secretion>
</substance>
 , <link xlink:type="simple" xlink:href="../537/645537.xml">
GnRH</link>, <substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../200/3062200.xml">
GHRH</link></hormone>
</part>
</liquid_body_substance>
</body_substance>
</secretion>
</substance>
, <link xlink:type="simple" xlink:href="../852/481852.xml">
somatostatin</link>, <link xlink:type="simple" xlink:href="../548/48548.xml">
dopamine</link> - <b> <link xlink:type="simple" xlink:href="../313/522313.xml">
Posterior pituitary</link>:</b> <link xlink:type="simple" xlink:href="../299/222299.xml">
vasopressin</link>, <link xlink:type="simple" xlink:href="../300/222300.xml">
oxytocin</link> - <b> <link xlink:type="simple" xlink:href="../177/335177.xml">
Anterior pituitary</link>:</b> <link xlink:type="simple" xlink:href="../901/5497901.xml">
α</link> (<link xlink:type="simple" xlink:href="../328/323328.xml">
FSH</link>, <link xlink:type="simple" xlink:href="../590/248590.xml">
LH</link>, <link xlink:type="simple" xlink:href="../361/330361.xml">
TSH</link>), <link xlink:type="simple" xlink:href="../072/173072.xml">
GH</link>, <link xlink:type="simple" xlink:href="../297/214297.xml">
prolactin</link>, <link xlink:type="simple" xlink:href="../544/183544.xml">
POMC</link> (<link xlink:type="simple" xlink:href="../997/57997.xml">
ACTH</link>, <link xlink:type="simple" xlink:href="../557/536557.xml">
MSH</link>, <link xlink:type="simple" xlink:href="../825/60825.xml">
endorphin</link>s, <link xlink:type="simple" xlink:href="../623/5708623.xml">
lipotropin</link>)</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#efefef;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../003/191003.xml">
Adrenal axis</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<b> <link xlink:type="simple" xlink:href="../ury/23rd_century.xml#xpointer(//*[./st=%22Adrenal+medulla%22])">
Adrenal medulla</link>:</b> <link xlink:type="simple" xlink:href="../250/10250.xml">
epinephrine</link>, <link xlink:type="simple" xlink:href="../342/9903342.xml">
norepinephrine</link> - <b> <link xlink:type="simple" xlink:href="../ury/23rd_century.xml#xpointer(//*[./st=%22Adrenal+cortex%22])">
Adrenal cortex</link>:</b>  <link xlink:type="simple" xlink:href="../130/375130.xml">
aldosterone</link>, <link xlink:type="simple" xlink:href="../380/335380.xml">
cortisol</link>, <link xlink:type="simple" xlink:href="../807/8807.xml">
DHEA</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#efefef;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../388/9542388.xml">
Thyroid axis</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<b> <link xlink:type="simple" xlink:href="../078/30078.xml">
Thyroid</link>:</b> <link xlink:type="simple" xlink:href="../584/18455584.xml">
thyroid hormone</link> (<link xlink:type="simple" xlink:href="../048/467048.xml">
T3</link> and <link xlink:type="simple" xlink:href="../893/144893.xml">
T4</link>) - <link xlink:type="simple" xlink:href="../058/467058.xml">
calcitonin</link> - <b> <link xlink:type="simple" xlink:href="../114/291114.xml">
Parathyroid</link>:</b> <link xlink:type="simple" xlink:href="../916/418916.xml">
PTH</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#efefef;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../693/2537693.xml">
Gonadal axis</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<b><link xlink:type="simple" xlink:href="../193/67193.xml">
Testis</link>:</b> <link xlink:type="simple" xlink:href="../983/30983.xml">
testosterone</link>, <link>
AMH</link>, <link xlink:type="simple" xlink:href="../521/1510521.xml">
inhibin</link> - <b> <link xlink:type="simple" xlink:href="../710/22710.xml">
Ovary</link>:</b> <link xlink:type="simple" xlink:href="../088/227088.xml">
estradiol</link>,  <link xlink:type="simple" xlink:href="../432/66432.xml">
progesterone</link>, <link xlink:type="simple" xlink:href="../521/1510521.xml">
inhibin</link>/<link xlink:type="simple" xlink:href="../577/1510577.xml">
activin</link>, <link xlink:type="simple" xlink:href="../480/3220480.xml">
relaxin</link>(pregnancy)</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#efefef;;" class="navbox-group">
Other end. glands</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<b> <link xlink:type="simple" xlink:href="../300/38300.xml">
Pancreas</link>:</b> <link xlink:type="simple" xlink:href="../953/249953.xml">
glucagon</link>, <link xlink:type="simple" xlink:href="../895/14895.xml">
insulin</link>, <link xlink:type="simple" xlink:href="../852/481852.xml">
somatostatin</link>  - <b> <link xlink:type="simple" xlink:href="../152/285152.xml">
Pineal gland</link>:</b> <link xlink:type="simple" xlink:href="../157/285157.xml">
melatonin</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#efefef;;" class="navbox-group">
Non-end. glands</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<b> <link xlink:type="simple" xlink:href="../166/67166.xml">
Placenta</link>:</b> <link xlink:type="simple" xlink:href="../445/300445.xml">
hCG</link>, <link xlink:type="simple" xlink:href="../885/4171885.xml">
HPL</link>, <link xlink:type="simple" xlink:href="../581/22581.xml">
estrogen</link>, <link xlink:type="simple" xlink:href="../432/66432.xml">
progesterone</link> - <b> <link xlink:type="simple" xlink:href="../025/17025.xml">
Kidney</link>:</b> <link xlink:type="simple" xlink:href="../978/251978.xml">
renin</link>, <link xlink:type="simple" xlink:href="../732/217732.xml">
EPO</link>, <link xlink:type="simple" xlink:href="../872/2200872.xml">
calcitriol</link>, <link xlink:type="simple" xlink:href="../336/92336.xml">
prostaglandin</link> - <b> <link xlink:type="simple" xlink:href="../242/1317242.xml">
Heart&nbsp;atrium</link>:</b> <substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../143/475143.xml">
ANP</link></hormone>
</part>
</liquid_body_substance>
</body_substance>
</secretion>
</substance>
 - <b> <link xlink:type="simple" xlink:href="../747/39747.xml">
Stomach</link>:</b> <link xlink:type="simple" xlink:href="../099/609099.xml">
gastrin</link>, <link xlink:type="simple" xlink:href="../527/768527.xml">
ghrelin</link> - <b> <link xlink:type="simple" xlink:href="../184/70184.xml">
Duodenum</link>: </b> <link xlink:type="simple" xlink:href="../568/533568.xml">
CCK</link>, <link xlink:type="simple" xlink:href="../278/1595278.xml">
GIP</link>, <link xlink:type="simple" xlink:href="../183/222183.xml">
secretin</link>, <link xlink:type="simple" xlink:href="../833/1833833.xml">
motilin</link>, <link xlink:type="simple" xlink:href="../896/1487896.xml">
VIP</link> - <b> <link xlink:type="simple" xlink:href="../599/99599.xml">
Ileum</link>: </b> <link xlink:type="simple" xlink:href="../997/2624997.xml">
enteroglucagon</link> -  <b> <link xlink:type="simple" xlink:href="../094/419094.xml">
Adipose tissue</link>:</b> <link xlink:type="simple" xlink:href="../938/214938.xml">
leptin</link>, <link xlink:type="simple" xlink:href="../980/707980.xml">
adiponectin</link>, <link xlink:type="simple" xlink:href="../225/731225.xml">
resistin</link> - <b><link xlink:type="simple" xlink:href="../265/56265.xml">
Thymus</link>:</b> <link xlink:type="simple" xlink:href="../347/2405347.xml">
Thymosin</link> - <link xlink:type="simple" xlink:href="../919/8174919.xml">
Thymopoietin</link> - <link xlink:type="simple" xlink:href="../802/15832802.xml">
Thymulin</link> - <b><link xlink:type="simple" xlink:href="../848/168848.xml">
Skeleton</link>:</b> <link xlink:type="simple" xlink:href="../478/4994478.xml">
Osteocalcin</link> - <b><link xlink:type="simple" xlink:href="../301/17384301.xml">
Liver</link>/</b>other: <substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../000/15000.xml">
Insulin-like growth factor</link></hormone>
</part>
</liquid_body_substance>
</body_substance>
</secretion>
</substance>
 (<substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../786/632786.xml">
IGF-1</link></hormone>
</part>
</liquid_body_substance>
</body_substance>
</secretion>
</substance>
, <substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../891/2602891.xml">
IGF-2</link></hormone>
</part>
</liquid_body_substance>
</body_substance>
</secretion>
</substance>
)</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#efefef;;" class="navbox-group">
Target-derived</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../863/2312863.xml">
NGF</link>, <substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../788/600788.xml">
BDNF</link></hormone>
</part>
</liquid_body_substance>
</body_substance>
</secretion>
</substance>
, <link xlink:type="simple" xlink:href="../261/5736261.xml">
NT-3</link></col>
</row>
</table>
</col>
</row>
</table>
</p>

<p>

<table style=";" class="navbox" cellspacing="0">
<row>
<col style="padding:2px;">
<table style="width:100%;background:transparent;color:inherit;;" class="nowraplinks collapsible autocollapse " cellspacing="0">
<row>
<header colspan="2" style=";" class="navbox-title">
<link xlink:type="simple" xlink:href="../491/689491.xml">
Sex hormone</link>s and related agents (primarily <written_communication wordnetid="106349220" confidence="0.8">
<code wordnetid="106667317" confidence="0.8">
<link xlink:type="simple" xlink:href="../368/839368.xml">
G03</link></code>
</written_communication>
, also <written_communication wordnetid="106349220" confidence="0.8">
<code wordnetid="106667317" confidence="0.8">
<link xlink:type="simple" xlink:href="../677/854677.xml">
L02</link></code>
</written_communication>
, <written_communication wordnetid="106349220" confidence="0.8">
<code wordnetid="106667317" confidence="0.8">
<link>
H01C</link></code>
</written_communication>
)&nbsp;– human endogenous in small caps</header>
</row>
<row style="height:2px;">

</row>
<row>
<col style=";background:#BBEEBB;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../987/239987.xml">
Progestogen</link>s:
(<structure wordnetid="105225602" confidence="0.8">
<cause wordnetid="107326557" confidence="0.8">
<beginning wordnetid="107290905" confidence="0.8">
<receptor wordnetid="105608868" confidence="0.8">
<happening wordnetid="107283608" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<origin wordnetid="107323922" confidence="0.8">
<factor wordnetid="107327805" confidence="0.8">
<part wordnetid="109385911" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<body_part wordnetid="105220461" confidence="0.8">
<link xlink:type="simple" xlink:href="../534/2246534.xml">
receptor</link></body_part>
</psychological_feature>
</part>
</factor>
</origin>
</event>
</happening>
</receptor>
</beginning>
</cause>
</structure>
)</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<table style="width:100%;;;;" class="nowraplinks  navbox-subgroup" cellspacing="0">
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
Agonist</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../432/66432.xml">
PROGESTERONE</link>&nbsp;· <link xlink:type="simple" xlink:href="../240/15222240.xml">
Dienogest</link>&nbsp;·  <link xlink:type="simple" xlink:href="../137/2444137.xml">
Desogestrel</link>&nbsp;·  <link xlink:type="simple" xlink:href="../141/2444141.xml">
Drospirenone</link>&nbsp;·  <link xlink:type="simple" xlink:href="../282/6662282.xml">
Dydrogesterone</link>&nbsp;·  <link xlink:type="simple" xlink:href="../174/6664174.xml">
Ethisterone</link>&nbsp;·  <link xlink:type="simple" xlink:href="../944/5310944.xml">
Etonogestrel</link>&nbsp;·  <link xlink:type="simple" xlink:href="../904/6657904.xml">
Ethynodiol diacetate</link>&nbsp;·  <link xlink:type="simple" xlink:href="../330/6658330.xml">
Gestodene</link>&nbsp;·  <link xlink:type="simple" xlink:href="../682/6659682.xml">
Gestonorone</link>&nbsp;·  <link xlink:type="simple" xlink:href="../277/675277.xml">
Levonorgestrel</link>&nbsp;·  <link xlink:type="simple" xlink:href="../945/6662945.xml">
Lynestrenol</link>&nbsp;·  <link xlink:type="simple" xlink:href="../071/6658071.xml">
Medroxyprogesterone</link>&nbsp;·  <link xlink:type="simple" xlink:href="../950/6657950.xml">
Megestrol</link>&nbsp;·  <link xlink:type="simple" xlink:href="../148/2444148.xml">
Norelgestromin</link>&nbsp;·   
<link xlink:type="simple" xlink:href="../979/6657979.xml">
Norethisterone</link>&nbsp;·  <link xlink:type="simple" xlink:href="../379/7721379.xml">
Norethynodrel</link>&nbsp;·  <link xlink:type="simple" xlink:href="../149/2444149.xml">
Norgestimate</link>&nbsp;·  <link xlink:type="simple" xlink:href="../267/2444267.xml">
Norgestrel</link>&nbsp;·  <link xlink:type="simple" xlink:href="../828/6662828.xml">
Norgestrienone</link>&nbsp;·  <link xlink:type="simple" xlink:href="../675/5162675.xml">
Tibolone</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../470/2537470.xml">
SPRM</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<physical_entity wordnetid="100001930" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<agent wordnetid="109190918" confidence="0.8">
<link xlink:type="simple" xlink:href="../462/11986462.xml">
Asoprisnil</link></agent>
</causal_agent>
</physical_entity>
&nbsp;·  <physical_entity wordnetid="100001930" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<agent wordnetid="109190918" confidence="0.8">
<link xlink:type="simple" xlink:href="../186/11995186.xml">
CDB-4124</link></agent>
</causal_agent>
</physical_entity>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
Antiprogestogen</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../415/181415.xml">
Mifepristone</link></col>
</row>
</table>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#BBEEBB;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../666/236666.xml">
Androgen</link>s:
(<structure wordnetid="105225602" confidence="0.8">
<cause wordnetid="107326557" confidence="0.8">
<beginning wordnetid="107290905" confidence="0.8">
<receptor wordnetid="105608868" confidence="0.8">
<happening wordnetid="107283608" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<origin wordnetid="107323922" confidence="0.8">
<factor wordnetid="107327805" confidence="0.8">
<part wordnetid="109385911" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<body_part wordnetid="105220461" confidence="0.8">
<link xlink:type="simple" xlink:href="../657/2246657.xml">
receptor</link></body_part>
</psychological_feature>
</part>
</factor>
</origin>
</event>
</happening>
</receptor>
</beginning>
</cause>
</structure>
)</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<table style="width:100%;;;;" class="nowraplinks  navbox-subgroup" cellspacing="0">
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
Agonist</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../983/30983.xml">
TESTOSTERONE</link>&nbsp;·  <link xlink:type="simple" xlink:href="../638/591638.xml">
Androstanolone</link>&nbsp;·  <link xlink:type="simple" xlink:href="../764/6662764.xml">
Fluoxymesterone</link>&nbsp;·  <link xlink:type="simple" xlink:href="../702/6662702.xml">
Mesterolone</link>&nbsp;·  <link xlink:type="simple" xlink:href="../442/723442.xml">
Methyltestosterone</link>&nbsp;·  <it>see also <link xlink:type="simple" xlink:href="../324/19218324.xml">
Anabolic steroids</link>''</it></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
<physical_entity wordnetid="100001930" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<agent wordnetid="109190918" confidence="0.8">
<link xlink:type="simple" xlink:href="../978/179978.xml">
Antiandrogen</link></agent>
</causal_agent>
</physical_entity>
</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<link xlink:type="simple" xlink:href="../496/1269496.xml">
Bicalutamide</link>&nbsp;·  <link xlink:type="simple" xlink:href="../311/1142311.xml">
Cyproterone</link>&nbsp;·  <link xlink:type="simple" xlink:href="../240/15222240.xml">
Dienogest</link>&nbsp;·  <link xlink:type="simple" xlink:href="../651/3308651.xml">
Flutamide</link>&nbsp;·  <link xlink:type="simple" xlink:href="../583/3374583.xml">
Nilutamide</link>&nbsp;·  <link xlink:type="simple" xlink:href="../656/732656.xml">
Spironolactone</link></col>
</row>
</table>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#BBEEBB;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../581/22581.xml">
Estrogen</link>s:
(<structure wordnetid="105225602" confidence="0.8">
<cause wordnetid="107326557" confidence="0.8">
<beginning wordnetid="107290905" confidence="0.8">
<receptor wordnetid="105608868" confidence="0.8">
<happening wordnetid="107283608" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<origin wordnetid="107323922" confidence="0.8">
<factor wordnetid="107327805" confidence="0.8">
<part wordnetid="109385911" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<body_part wordnetid="105220461" confidence="0.8">
<link xlink:type="simple" xlink:href="../134/1581134.xml">
receptor</link></body_part>
</psychological_feature>
</part>
</factor>
</origin>
</event>
</happening>
</receptor>
</beginning>
</cause>
</structure>
)</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<table style="width:100%;;;;" class="nowraplinks  navbox-subgroup" cellspacing="0">
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
Agonist</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../088/227088.xml">
ESTRADIOL</link>&nbsp;·  <link xlink:type="simple" xlink:href="../360/647360.xml">
ESTRIOL</link>&nbsp;·  <link xlink:type="simple" xlink:href="../095/470095.xml">
ESTRONE</link>&nbsp;·  <substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<estrogen wordnetid="114749794" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<steroid_hormone wordnetid="114745635" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../470/6662470.xml">
Chlorotrianisene</link></hormone>
</steroid_hormone>
</part>
</liquid_body_substance>
</body_substance>
</estrogen>
</secretion>
</substance>
&nbsp;·  <substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<estrogen wordnetid="114749794" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<steroid_hormone wordnetid="114745635" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../400/6662400.xml">
Dienestrol</link></hormone>
</steroid_hormone>
</part>
</liquid_body_substance>
</body_substance>
</estrogen>
</secretion>
</substance>
&nbsp;·  <link xlink:type="simple" xlink:href="../975/294975.xml">
Diethylstilbestrol</link>&nbsp;·  <substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<estrogen wordnetid="114749794" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<steroid_hormone wordnetid="114745635" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../454/2421454.xml">
Ethinylestradiol</link></hormone>
</steroid_hormone>
</part>
</liquid_body_substance>
</body_substance>
</estrogen>
</secretion>
</substance>
&nbsp;·  <physical_entity wordnetid="100001930" confidence="0.8">
<substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<estrogen wordnetid="114749794" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<agent wordnetid="109190918" confidence="0.8">
<steroid_hormone wordnetid="114745635" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../774/6661774.xml">
Fosfestrol</link></hormone>
</steroid_hormone>
</agent>
</part>
</causal_agent>
</liquid_body_substance>
</body_substance>
</estrogen>
</secretion>
</substance>
</physical_entity>
&nbsp;·  <link xlink:type="simple" xlink:href="../911/7721911.xml">
Mestranol</link>&nbsp;·  <substance wordnetid="100019613" confidence="0.8">
<secretion wordnetid="105404728" confidence="0.8">
<estrogen wordnetid="114749794" confidence="0.8">
<body_substance wordnetid="105263850" confidence="0.8">
<liquid_body_substance wordnetid="105397468" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<steroid_hormone wordnetid="114745635" confidence="0.8">
<hormone wordnetid="105407119" confidence="0.8">
<link xlink:type="simple" xlink:href="../511/3295511.xml">
Polyestradiol phosphate</link></hormone>
</steroid_hormone>
</part>
</liquid_body_substance>
</body_substance>
</estrogen>
</secretion>
</substance>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../710/1088710.xml">
SERM</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<link xlink:type="simple" xlink:href="../459/16577459.xml">
Afimoxifene</link>&nbsp;·  <link xlink:type="simple" xlink:href="../464/16782464.xml">
Arzoxifene</link>&nbsp;·  <link xlink:type="simple" xlink:href="../896/2824896.xml">
Bazedoxifene</link>&nbsp;·  <link xlink:type="simple" xlink:href="../916/1085916.xml">
Clomifene</link>&nbsp;·  <work wordnetid="100575741" confidence="0.8">
<treatment wordnetid="100658082" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<care wordnetid="100654885" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<activity wordnetid="100407535" confidence="0.8">
<link xlink:type="simple" xlink:href="../631/1269631.xml">
Fulvestrant</link></activity>
</psychological_feature>
</act>
</care>
</event>
</treatment>
</work>
&nbsp;·  <link xlink:type="simple" xlink:href="../851/10948851.xml">
Lasofoxifene</link>&nbsp;·  <link xlink:type="simple" xlink:href="../623/1845623.xml">
Raloxifene</link>&nbsp;·  <link xlink:type="simple" xlink:href="../557/1269557.xml">
Tamoxifen</link>&nbsp;·  <link xlink:type="simple" xlink:href="../295/3335295.xml">
Toremifene</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
<physical_entity wordnetid="100001930" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<agent wordnetid="109190918" confidence="0.8">
<link xlink:type="simple" xlink:href="../073/1547073.xml">
AI</link></agent>
</causal_agent>
</physical_entity>
</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<substance wordnetid="100020090" confidence="0.8">
<inhibitor wordnetid="114724436" confidence="0.8">
<link xlink:type="simple" xlink:href="../115/2984115.xml">
Aminoglutethimide</link></inhibitor>
</substance>
&nbsp;·  <substance wordnetid="100020090" confidence="0.8">
<inhibitor wordnetid="114724436" confidence="0.8">
<link xlink:type="simple" xlink:href="../389/332389.xml">
Anastrozole</link></inhibitor>
</substance>
&nbsp;·  <substance wordnetid="100020090" confidence="0.8">
<inhibitor wordnetid="114724436" confidence="0.8">
<link xlink:type="simple" xlink:href="../359/14416359.xml">
Atamestane</link></inhibitor>
</substance>
&nbsp;·  <substance wordnetid="100020090" confidence="0.8">
<inhibitor wordnetid="114724436" confidence="0.8">
<link xlink:type="simple" xlink:href="../222/3173222.xml">
Exemestane</link></inhibitor>
</substance>
&nbsp;·  <link xlink:type="simple" xlink:href="../927/18644927.xml">
Fadrozole</link>&nbsp;·  <substance wordnetid="100020090" confidence="0.8">
<inhibitor wordnetid="114724436" confidence="0.8">
<link xlink:type="simple" xlink:href="../023/6662023.xml">
Formestane</link></inhibitor>
</substance>
&nbsp;·  <substance wordnetid="100020090" confidence="0.8">
<inhibitor wordnetid="114724436" confidence="0.8">
<link xlink:type="simple" xlink:href="../912/2884912.xml">
Letrozole</link></inhibitor>
</substance>
&nbsp;·  <substance wordnetid="100020090" confidence="0.8">
<inhibitor wordnetid="114724436" confidence="0.8">
<link xlink:type="simple" xlink:href="../079/6662079.xml">
Vorozole</link></inhibitor>
</substance>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
Antiestrogen</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<link xlink:type="simple" xlink:href="../901/18250901.xml">
Mepitiostane</link></col>
</row>
</table>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#BBEEBB;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../767/722767.xml">
Gonadotropin</link>s:
(<structure wordnetid="105225602" confidence="0.8">
<receptor wordnetid="105608868" confidence="0.8">
<part wordnetid="109385911" confidence="0.8">
<body_part wordnetid="105220461" confidence="0.8">
<link xlink:type="simple" xlink:href="../828/5746828.xml">
FSHR</link></body_part>
</part>
</receptor>
</structure>
/<structure wordnetid="105225602" confidence="0.8">
<receptor wordnetid="105608868" confidence="0.8">
<part wordnetid="109385911" confidence="0.8">
<body_part wordnetid="105220461" confidence="0.8">
<link xlink:type="simple" xlink:href="../713/5760713.xml">
LHCGR</link></body_part>
</part>
</receptor>
</structure>
)</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<table style="width:100%;;;;" class="nowraplinks  navbox-subgroup" cellspacing="0">
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../856/161856.xml">
ovulation</link>stim.</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../916/1085916.xml">
Clomifene</link>&nbsp;·  <physical_entity wordnetid="100001930" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<agent wordnetid="109190918" confidence="0.8">
<link xlink:type="simple" xlink:href="../720/2294720.xml">
Urofollitropin</link></agent>
</causal_agent>
</physical_entity>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
Antigonadotropin</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<physical_entity wordnetid="100001930" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<agent wordnetid="109190918" confidence="0.8">
<link xlink:type="simple" xlink:href="../477/3370477.xml">
Danazol</link></agent>
</causal_agent>
</physical_entity>
&nbsp;·  <link xlink:type="simple" xlink:href="../864/5366864.xml">
Gestrinone</link></col>
</row>
</table>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:#BBEEBB;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../537/645537.xml">
GnRH</link>:
(<structure wordnetid="105225602" confidence="0.8">
<receptor wordnetid="105608868" confidence="0.8">
<part wordnetid="109385911" confidence="0.8">
<body_part wordnetid="105220461" confidence="0.8">
<link xlink:type="simple" xlink:href="../818/3922818.xml">
receptor</link></body_part>
</part>
</receptor>
</structure>
)</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<table style="width:100%;;;;" class="nowraplinks  navbox-subgroup" cellspacing="0">
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
<physical_entity wordnetid="100001930" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<agent wordnetid="109190918" confidence="0.8">
<link xlink:type="simple" xlink:href="../814/3380814.xml">
Agonist</link></agent>
</causal_agent>
</physical_entity>
</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<protagonist wordnetid="110172793" confidence="0.8">
<link xlink:type="simple" xlink:href="../388/2102388.xml">
Buserelin</link></protagonist>
&nbsp;·  <protagonist wordnetid="110172793" confidence="0.8">
<link xlink:type="simple" xlink:href="../468/1269468.xml">
Goserelin</link></protagonist>
&nbsp;·  <protagonist wordnetid="110172793" confidence="0.8">
<link xlink:type="simple" xlink:href="../042/8316042.xml">
Histrelin</link></protagonist>
&nbsp;·  <protagonist wordnetid="110172793" confidence="0.8">
<link xlink:type="simple" xlink:href="../519/1336519.xml">
Leuprorelin</link></protagonist>
&nbsp;·  <protagonist wordnetid="110172793" confidence="0.8">
<link xlink:type="simple" xlink:href="../271/2102271.xml">
Nafarelin</link></protagonist>
&nbsp;·  <protagonist wordnetid="110172793" confidence="0.8">
<link xlink:type="simple" xlink:href="../756/3374756.xml">
Triptorelin</link></protagonist>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: #BBEEBB;;" class="navbox-group">
<physical_entity wordnetid="100001930" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<agent wordnetid="109190918" confidence="0.8">
<link xlink:type="simple" xlink:href="../832/3380832.xml">
Antagonist</link></agent>
</causal_agent>
</physical_entity>
</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<physical_entity wordnetid="100001930" confidence="0.8">
<person wordnetid="100007846" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<adversary wordnetid="109773245" confidence="0.8">
<link xlink:type="simple" xlink:href="../790/1300790.xml">
Abarelix</link></adversary>
</causal_agent>
</person>
</physical_entity>
&nbsp;·  <physical_entity wordnetid="100001930" confidence="0.8">
<person wordnetid="100007846" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<adversary wordnetid="109773245" confidence="0.8">
<link xlink:type="simple" xlink:href="../465/9543465.xml">
Cetrorelix</link></adversary>
</causal_agent>
</person>
</physical_entity>
&nbsp;·  <physical_entity wordnetid="100001930" confidence="0.8">
<person wordnetid="100007846" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<adversary wordnetid="109773245" confidence="0.8">
<link xlink:type="simple" xlink:href="../638/9526638.xml">
Ganirelix</link></adversary>
</causal_agent>
</person>
</physical_entity>
</col>
</row>
</table>
</col>
</row>
</table>
</col>
</row>
</table>
</p>



</sec>
</bdy>
</entity>
</article>
